Seaport Therapeutics, Inc. (SPTX)
17.15
-1.00
(-5.51%)
USD |
NASDAQ |
Oct 12, 16:00
17.09
-0.06
(-0.35%)
After-Hours: 20:00
Seaport Therapeutics Net Income (Quarterly) : -62.60M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -62.60M |
| March 31, 2026 | -25.41M |
| Date | Value |
|---|---|
| June 30, 2025 | -15.08M |
| March 31, 2025 | -13.12M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Johnson & Johnson | 5.534B |
| Bristol Myers Squibb Co. | 3.316B |
| Harmony Biosciences Holdings, Inc. | 75.43M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 62.60M |
| EPS Diluted (Quarterly) | -1.169 |
| Enterprise Value | 649.76M |
| Earnings Yield | -12.66% |
| Normalized Earnings Yield | -12.66 |